In this regard, HDAC6 inhibitors have demonstrated encouraging anti-MM activity, mainly due to their capability to disrupt the aggresome-autophagy pathway and induce apoptosis in MM cells. This evidence concerns the gene HDAC6 and Miyoshi myopathy.